Related Experiment Video

Updated: Jan 22, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
07:35

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data

Published on: December 1, 2023

1.1K

SNHG15: a promising cancer-related long noncoding RNA

Jinfei Tong1,2, Xudong Ma1,2, Hailan Yu1,2

  • 1Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

Cancer Management and Research
|July 17, 2019
PubMed

Insights

Small nucleolar RNA host gene 15 (SNHG15) is upregulated in many cancers and drives tumor growth and spread. This long noncoding RNA (lncRNA) shows promise as a biomarker for cancer diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Cancer is a leading global cause of death, with increasing morbidity and mortality.
  • Long noncoding RNAs (lncRNAs) are crucial regulators of biological processes, including cancer development.
  • Small nucleolar RNA host gene 15 (SNHG15) is frequently overexpressed in tumors.

Purpose of the Study:

  • To review the biological functions and molecular mechanisms of SNHG15 in various cancers.
  • To explore the role of SNHG15 in cancer cell proliferation, migration, and invasion.
  • To assess SNHG15 as a potential biomarker for cancer diagnosis, prognosis, and treatment.

Main Methods:

  • Literature review of studies on SNHG15 in cancer.
  • Analysis of SNHG15 expression patterns in different cancer types.
  • Summary of documented molecular mechanisms involving SNHG15.

Main Results:

  • SNHG15 is upregulated in gastric, liver, pancreatic, colorectal, breast, thyroid, bone, brain, lung, kidney, and ovarian cancers.
  • SNHG15 regulates tumor cell proliferation, migration, and invasion through diverse mechanisms.
  • Abnormal SNHG15 expression correlates with clinical features in cancer patients.

Conclusions:

  • SNHG15 is implicated in the development and progression of multiple cancers.
  • SNHG15 exhibits potential as a diagnostic, prognostic, and therapeutic biomarker in oncology.
  • Further research into SNHG15 mechanisms could yield novel cancer treatment strategies.
Keywords:
SNHG15biomarkercancerlong noncoding RNA

More Related Videos

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

9.3K
Isolation of Small Noncoding RNAs from Human Serum06:44

Isolation of Small Noncoding RNAs from Human Serum

Published on: June 19, 2014

18.5K

Related Concept Videos

RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.6K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.9K
RNA Structure01:23

RNA Structure

Overview
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
78.9K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.4K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
26.8K